Chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) mainly expresses type-2 endotype, featuring eosinophils as a main player in the inflammatory process. Prolonged eosinophilia in the tissues of ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd.

Suggested remit: To appraise the clinical and cost effectiveness of benralizumab within its marketing authorisation for previously treated severe nasal polyps. As you will be aware, the Department for ...

Similarly, initiations fell from 21% to 9% for mepolizumab (Nucala, GSK), from 3% to 1% for reslizumab (Cinqair, Teva Pharmaceuticals) and from 42% to 16% for benralizumab (Fasenra, AstraZeneca).

FASENRA® (benralizumab) injection for subcutaneous use is approved for the treatment of adults with EGPA. For the treatment of EGPA, the recommended dosage of FASENRA is 30 mg (one injection ...

Last December, the Department of Health and Human Services proposed a rule that would make data encryption a standard and not optional across healthcare organizations that store and transfer ...